The basis of molecular strategies for treating coronary restenosis after angioplasty.
about
Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplastyOptimization of cardiovascular stent against restenosis: factorial design-based statistical analysis of polymer coating conditionsNovel approaches for the prevention of restenosis.Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbitThe antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.Below-the-knee drug-eluting stents and drug-coated balloons.Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres.Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture.Increasing our IQ of vascular smooth muscle cell migration with IQGAP1. Focus on "IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury".
P2860
Q28192448-2F73A18F-B061-405E-A1B6-FAC7CD4C5120Q28482479-104FB7D6-F58C-414F-85B1-55251CF156E3Q34075160-6C77BFF4-28D5-4735-97E5-BAF4ADCE6579Q34223710-18667218-D13E-4014-8121-6CA7A4B2CC76Q34407499-CFBEBD5A-57BC-45E4-8B55-7AFFFA683FEDQ35763997-766F2D33-C494-4837-8EFF-9FB5F5018984Q37965246-9DD0E52F-6CF2-424D-8D0C-EE263E091FCAQ38549669-406FE69B-76E9-4EA0-A3D3-FB808F8F4C4EQ42178648-E6A6C2BC-FD58-4233-BAFE-74BD86DA931FQ42582634-5D1C95AB-6774-4C9D-A662-C12AA0A31BD7
P2860
The basis of molecular strategies for treating coronary restenosis after angioplasty.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The basis of molecular strategies for treating coronary restenosis after angioplasty.
@en
type
label
The basis of molecular strategies for treating coronary restenosis after angioplasty.
@en
prefLabel
The basis of molecular strategies for treating coronary restenosis after angioplasty.
@en
P2093
P1476
The basis of molecular strategies for treating coronary restenosis after angioplasty.
@en
P2093
P304
P356
10.1016/0735-1097(94)90368-9
P407
P577
1994-05-01T00:00:00Z